Drug Alerts & Information

Alerts about drug supply changes and other information will be posted here as appropriate.

US Food and Drug Administration Information

Pediatric Malignancies with TNF Blocking Agents: 2009 ACR/ARHP Annual Meeting Presentation Slides

Information on Rheumatology Therapeutics

Postmarket Drug Safety Information for Patients and Providers

Medwatch: FDA Safety Information and Adverse Reporting System

US Food and Drug Administration Recalls and Safety Alerts

FDA Arthritis Advisory Committee Hearings

The FDA Arthritis Advisory Committee meets periodically to discuss therapies, pharmaceuticals, and clinical trials, among other topics.

By law, anyone can participate in the rule-making process by presenting data, information or views -- orally or in writing -- on issues pending before the committee. The AAC meets 4-6 times per year to review new drug applications and applications for additional indications. Its recommendations are highly considered in the final FDA decision. Announcements of upcoming meetings are made with as little as 15 days' notice.

AAC Links

Advisory Committees Home Page:
http://www.fda.gov/oc/advisory/default.htm

2008 AAC Meetings (Notices, Agendas, Transcripts):
http://www.fda.gov/ohrms/dockets/ac/cder08.html#ArthritisDrugs

AAC Committee Roster:
http://www.fda.gov/cder/audiences/acspage/arthritisroster1.htm

AAC Charter:
http://www.fda.gov/cder/audiences/acspage/Arthritischarter1.htm